Amends TCA Title 4; Title 53; Title 56; Title 68 and Title 71.

Tennessee HB1198 amends various sections of the Tennessee Code Annotated to authorize the bureau of TennCare to implement cost-saving measures for pharmaceutical services, specifically allowing the use of biosimilars. The bill affects health carriers, health benefit plans, and individuals lacking prescription drug insurance coverage by enabling the requirement to try biosimilars before branded drugs and mandating their use in certain cases. Key provisions include the expansion of step therapy protocols to include biosimilars and the requirement for the TennCare pharmacy advisory committee to consider biosimilars in its recommendations for the preferred drug list.